Literature DB >> 27501124

A Mouse Model of Retinal Ischemia-Reperfusion Injury Through Elevation of Intraocular Pressure.

Matthew J Hartsock1, Hongkwan Cho1, Lijuan Wu1, Wan-Ju Chen1, Junsong Gong1, Elia J Duh2.   

Abstract

Retinal ischemia-reperfusion (I/R) is a pathophysiological process contributing to cellular damage in multiple ocular conditions, including glaucoma, diabetic retinopathy, and retinal vascular occlusions. Rodent models of I/R injury are providing significant insights into mechanisms and treatment strategies for human I/R injury, especially with regard to neurodegenerative damage in the retinal neurovascular unit. Presented here is a protocol for inducing retinal I/R injury in mice through elevation of intraocular pressure (IOP). In this protocol, the ocular anterior chamber is cannulated with a needle, through which flows the drip of an elevated saline reservoir. Using this drip to raise IOP above systolic arterial blood pressure, a practitioner temporarily halts inner retinal blood flow (ischemia). When circulation is reinstated (reperfusion) by removal of the cannula, severe cellular damage ensues, resulting ultimately in retinal neurodegeneration. Recent studies demonstrate inflammation, vascular permeability, and capillary degeneration as additional elements of this model. Compared to alternative retinal I/R methodologies, such as retinal arterial ligation, retinal I/R injury by elevated IOP offers advantages in its anatomical specificity, experimental tractability, and technical accessibility, presenting itself as a valuable tool for examining neuronal pathogenesis and therapy in the retinal neurovascular unit.

Entities:  

Mesh:

Year:  2016        PMID: 27501124      PMCID: PMC5091361          DOI: 10.3791/54065

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  30 in total

1.  Statin inhibits leukocyte-endothelial interaction and prevents neuronal death induced by ischemia-reperfusion injury in the rat retina.

Authors:  Megumi Honjo; Hidenobu Tanihara; Kazuaki Nishijima; Junichi Kiryu; Yoshihito Honda; Beatrice Y J T Yue; Tatsuya Sawamura
Journal:  Arch Ophthalmol       Date:  2002-12

2.  Expression of c-fos and c-jun mRNA following transient retinal ischemia: an approach using ligation of the retinal central artery in the rat.

Authors:  Y Otori; S Shimada; H Morimura; I Ishimoto; M Tohyama; Y Tano
Journal:  Surv Ophthalmol       Date:  1997-11       Impact factor: 6.048

3.  Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes.

Authors:  Ling Zheng; Bendi Gong; Denise A Hatala; Timothy S Kern
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-01       Impact factor: 4.799

4.  Neuroprotective role of Nrf2 for retinal ganglion cells in ischemia-reperfusion.

Authors:  Zhenhua Xu; Hongkwan Cho; Matthew J Hartsock; Katherine L Mitchell; Junsong Gong; Lijuan Wu; Yanhong Wei; Shuang Wang; Rajesh K Thimmulappa; Michael B Sporn; Shyam Biswal; Derek S Welsbie; Elia J Duh
Journal:  J Neurochem       Date:  2015-03-04       Impact factor: 5.372

Review 5.  Free radicals in retinal ischemia.

Authors:  C Bonne; A Muller; M Villain
Journal:  Gen Pharmacol       Date:  1998-03

6.  Effects of ischemic preconditioning and bevacizumab on apoptosis and vascular permeability following retinal ischemia-reperfusion injury.

Authors:  Steven F Abcouwer; Cheng-mao Lin; Ellen B Wolpert; Sumathi Shanmugam; Eric W Schaefer; Willard M Freeman; Alistair J Barber; David A Antonetti
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-16       Impact factor: 4.799

7.  Lomerizine, a Ca2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina.

Authors:  N Toriu; A Akaike; H Yasuyoshi; S Zhang; S Kashii; Y Honda; M Shimazawa; H Hara
Journal:  Exp Eye Res       Date:  2000-04       Impact factor: 3.467

Review 8.  Retinal ischemia: mechanisms of damage and potential therapeutic strategies.

Authors:  Neville N Osborne; Robert J Casson; John P M Wood; Glyn Chidlow; Mark Graham; José Melena
Journal:  Prog Retin Eye Res       Date:  2004-01       Impact factor: 21.198

9.  Progressive morphological changes and impaired retinal function associated with temporal regulation of gene expression after retinal ischemia/reperfusion injury in mice.

Authors:  Byung-Jin Kim; Terry A Braun; Robert J Wordinger; Abbot F Clark
Journal:  Mol Neurodegener       Date:  2013-06-22       Impact factor: 14.195

10.  Minocycline prevents retinal inflammation and vascular permeability following ischemia-reperfusion injury.

Authors:  Steven F Abcouwer; Cheng-Mao Lin; Sumathi Shanmugam; Arivalagan Muthusamy; Alistair J Barber; David A Antonetti
Journal:  J Neuroinflammation       Date:  2013-12-10       Impact factor: 8.322

View more
  34 in total

1.  Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma.

Authors:  Chaobin Lin; Fujin Wu; Tongmei Zheng; Xiuchun Wang; Yiwei Chen; Xiaomin Wu
Journal:  Eye (Lond)       Date:  2018-12-18       Impact factor: 3.775

2.  Intracameral injection of a chemically cross-linked hydrogel to study chronic neurodegeneration in glaucoma.

Authors:  Kevin C Chan; Yu Yu; Shuk Han Ng; Heather K Mak; Yolanda W Y Yip; Yolandi van der Merwe; Tianmin Ren; Jasmine S Y Yung; Sayantan Biswas; Xu Cao; Ying Chau; Christopher K S Leung
Journal:  Acta Biomater       Date:  2019-06-06       Impact factor: 8.947

3.  Immediate IOP elevation after transscleral cyclophotocoagulation.

Authors:  M R Razeghinejad; A Hamid; M H Nowroozzadeh
Journal:  Eye (Lond)       Date:  2017-04-07       Impact factor: 3.775

4.  A Contrast in Pathogenic Responses between C57BL/6J and BALB/cJ Mice Using a Model of Retinal Injury.

Authors:  Haoshen Shi; Abdul S Ebrahim; Elizabeth A Berger
Journal:  Am J Pathol       Date:  2018-09-18       Impact factor: 4.307

5.  Houttuynia cordata Thunb rescues retinal ganglion cells through inhibiting microglia activation in a rat model of retinal ischemia-reperfusion.

Authors:  Le-Meng Ren; Ying-Hui Zhang
Journal:  Int J Ophthalmol       Date:  2020-12-18       Impact factor: 1.779

Review 6.  Diabetic retinopathy: current understanding, mechanisms, and treatment strategies.

Authors:  Elia J Duh; Jennifer K Sun; Alan W Stitt
Journal:  JCI Insight       Date:  2017-07-20

7.  Involvement of moesin phosphorylation in ischemia/reperfusion induced inner blood-retinal barrier dysfunction.

Authors:  Jing Xu; Qiong Liu; Ming Ma; Lin-Jiang Chen; Jian Yu; Ke Xiong; Jing Wu
Journal:  Int J Ophthalmol       Date:  2020-04-18       Impact factor: 1.779

8.  Inhibition of the Keap1-Nrf2 protein-protein interaction protects retinal cells and ameliorates retinal ischemia-reperfusion injury.

Authors:  Qiaoyan Hui; Marcus Karlstetter; Zhenhua Xu; Jing Yang; Lingli Zhou; Hanna M Eilken; Carsten Terjung; Hongkwan Cho; Junsong Gong; Michael J Lai; Khaled Nassar; Elia J Duh
Journal:  Free Radic Biol Med       Date:  2019-11-07       Impact factor: 7.376

9.  Knock-Out of Tenascin-C Ameliorates Ischemia-Induced Rod-Photoreceptor Degeneration and Retinal Dysfunction.

Authors:  Susanne Wiemann; Aisha Yousf; Stephanie C Joachim; Carolin Peters; Ana M Mueller-Buehl; Natalie Wagner; Jacqueline Reinhard
Journal:  Front Neurosci       Date:  2021-05-20       Impact factor: 4.677

10.  The Regulatory NOD-Like Receptor NLRC5 Promotes Ganglion Cell Death in Ischemic Retinopathy by Inducing Microglial Pyroptosis.

Authors:  Yang Deng; Yunzhao Fu; Longxiang Sheng; Yixin Hu; Lishi Su; Jiawen Luo; Chun Yan; Wei Chi
Journal:  Front Cell Dev Biol       Date:  2021-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.